Adelaide Research & Scholarship: Search

Search

Results 11-20 of 24 (Search time: 0.004 seconds).

Item hits:

Preview	Issue Date	Title	Author(s)
	2003	Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy	Bouralexis, S.; Findlay, D.; Atkins, G.; Labrinidis, A.; Hay, S.; Evdokiou, A.
	2011	Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo	Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.; Zannettino, A.; Evdokiou, A.
	2010	Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model	Labrinidis, A.; Hay, S.; Liapis, V.; Findlay, D.; Evdokiou, A.
	2002	Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis	Atkins, G.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Labrinidis, A.; Zannettino, A.; Haynes, D.; Findlay, D.
	2000	Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells	Kitahama, S.; Gibson, M.; Hatzinikolas, G.; Hay, S.; Kuliwaba, J.; Evdokiou, A.; Atkins, G.; Findlay, D.
	2003	Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis	Evdokiou, A.; Labrinidis, A.; Bouralexis, S.; Hay, S.; Findlay, D.
	2008	Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?	Labrinidis, A.; Liapis, V.; Thai, L.; Atkins, G.; Vincent, C.; Hay, S.; Sims, N.; Zannettino, A.; Findlay, D.; Evdokiou, A.
	2008	Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males	Findlay, D.; Chehade, M.; Tsangari, H.; Neale, S.; Hay, S.; Hopwood, B.; Pannach, S.; O'Loughlin, P.; Fazzalari, N.
	2009	Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer	Zinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A.
	2009	Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma	Labrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A.